Clinical Trials on Giant Cavernous Hemangiomas in Portugal
Total 6 results
-
Novartis PharmaceuticalsActive, not recruitingGiant Cell Arteritis (GCA)United States, Belgium, Hungary, Italy, Turkey, Austria, Spain, Switzerland, France, Germany, Israel, Australia, Denmark, Greece, United Kingdom, Guatemala, Bulgaria, Czechia, Estonia, Argentina, Canada, Brazil, Sweden, Finland, Poland, P... and more
-
AbbVieActive, not recruitingGiant Cell Arteritis (GCA)United States, Australia, Austria, Belgium, Canada, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Portugal, Romania, Russian Federation, Spain, Sweden, Switzerland, United...
-
University of OxfordLondon School of Hygiene and Tropical Medicine; The Leeds Teaching Hospitals... and other collaboratorsCompletedGiant Cell ArteritisIreland, United Kingdom, Germany, Norway, Portugal
-
SanofiRegeneron PharmaceuticalsTerminatedGiant Cell ArteritisArgentina, Estonia, France, United States, Australia, Belgium, Canada, Croatia, Denmark, Germany, Hungary, Israel, Italy, Netherlands, Portugal, Russian Federation, Slovenia, Spain, Sweden, Switzerland, United Kingdom
-
Hoffmann-La RocheCompletedGiant Cell ArteritisUnited States, United Kingdom, Sweden, Belgium, Netherlands, Germany, Spain, Norway, Poland, France, Italy, Canada, Denmark, Portugal
-
University of OxfordAmerican College of Rheumatology; The European League Against Rheumatism (EULAR) and other collaboratorsUnknownGiant Cell Arteritis | Wegener's Granulomatosis | Microscopic Polyangiitis | Polyarteritis Nodosa | Takayasu Arteritis | Churg Strauss SyndromeKorea, Republic of, United States, Germany, Australia, Japan, Ireland, Belgium, Italy, Denmark, Slovenia, Switzerland, Canada, Argentina, Austria, China, Czech Republic, Egypt, Finland, France, Hungary, India, Mexico, Netherlands, New... and more